Ocumension Therapeutics (FRA:5DG)
Germany
· Delayed Price · Currency is EUR 0.8900
+0.0100 (1.14%)
At close: Dec 5, 2025
Ocumension Therapeutics Revenue
Ocumension Therapeutics had revenue of 294.03M CNY in the half year ending June 30, 2025, with 183.55% growth. This brings the company's revenue in the last twelve months to 543.72M, up 75.23% year-over-year. In the year 2024, Ocumension Therapeutics had annual revenue of 417.31M with 69.38% growth.
Revenue (ttm)
543.72M CNY
Revenue Growth
+75.23%
P/S Ratio
11.56
Revenue / Employee
1.11M CNY
Employees
489
Market Cap
747.30M EUR
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Rheinmetall AG | 11.00B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Deutsche Bank Aktiengesellschaft | 29.86B |